CRYO — American Cryostem Cashflow Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $0.99m
- $0.02m
Annual cashflow statement for American Cryostem, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2017 September 30th | 2018 September 30th | 2019 September 30th | 2020 September 30th | 2021 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1.22 | -1.49 | -1.08 | -1.18 | -2.88 |
| Depreciation | |||||
| Non-Cash Items | 1.34 | 0.736 | 0.278 | 1.05 | 1.75 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.176 | 0.553 | 0.275 | -0.416 | 0.756 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 0.333 | -0.174 | -0.497 | -0.515 | -0.304 |
| Capital Expenditures | -0.073 | -0.225 | -0.05 | -0.013 | -0.043 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0 | -0.3 | 0 | — | -0.049 |
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.073 | -0.525 | -0.05 | -0.013 | -0.091 |
| Financing Cash Flow Items | -0.009 | -0.001 | 0.103 | -0.011 | 0.049 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.113 | 0.357 | 0.502 | 0.545 | 0.362 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.373 | -0.342 | -0.045 | 0.018 | -0.034 |